Financial Results

COVID-19 disruption: Bubs’ gross revenue in China down 66% in Q2, new sales channel delayed

06-Feb-2023 By Tingmin Koe

Infant formula producer Bubs Australia said its gross revenue has China dropped by 66 per cent, and its new Manufacturer-to-Consumer (M2C) sale channel in the country has been delayed, due to disruptions caused by China’s prolonged COVID-19 lockdowns.

Rapid innovation: Accelerated NPD strategy reaps rewards for Chinese dairy giant Yili

20-Sep-2022 By Pearly Neo

China dairy giant Yili has registered record growth and increased market share in its recently-released H1FY2022 financial report, and has attributed this success to the sales of its value-added dairy products as well as its efforts in rapid new product...

Financial updates: a2 milk, Blackmores, Meiji, BYHEALTH

02-Sep-2022 By Tingmin Koe

This round-up looks at the latest financial report from major dietary supplement and infant formula firms, namely The a2 Milk Company, Blackmores, McPherson’s, Meiji, and BYHEALTH.

Glanbia bumps full-year outlook by 4% after ‘very solid’ HY 2022 performance

18-Aug-2022 By Teodora Lyubomirova

Dairy portfolio is outperformed in nutritionals, but US cheese records growth and SlimFast is set for a re-brand ahead of 2023.

Hochdorf nets China approval, predicts 'difficult earnings and cost situation'

08-Aug-2022 By Teodora Lyubomirova

The Swiss nutrition specialist has received approval to manufacture products for the Chinese infant nutrition market but EBIT is down year-on-year.